CDMO PLATFORM
Agile and flexible CDMO services tailored to your requirements
CAPABILITIES
Reliable and world-class biological contract development and manufacturing
We are a global CDMO, specializing in the development and manufacture of biologics. We work closely with you on every project to offer a personalized service, responding with agility to meet your exact manufacturing needs. We offer our 10+ years of experience in the development, manufacture and commercialization of biopharmaceutical medicines.
Our CDMO services are fully integrated and flexible: from formulation to fill & finish, small-scale or large quantities, R&D and commercial batches. In all our processes we apply high-quality, innovative technologies at our well-invested facilities to help accelerate programs and facilitate early market entry.
Single-Use Technology
1
Manufacturing
2
Filling
3
Finishing
We use large-scale, single-use bioreactor technology that allows efficient change over and minimizes potential cross contamination.
mAbxience expertise
Ready To Use (RTU) and Ready To Sterilize (RTS) vials and syringes eliminate cross contamination risks. There is also reduction of facilities’ environmental impact and less capital investment required.
Filling and packaging operations at our partners sites
PRODUCTS
Specialized in customized CDMO solutions for biopharmaceuticals and complex proteins
Our expertise is in the field of biopharmaceutical development and manufacturing, combined with strong analytical capabilities. Our core competencies are applied to vaccines, immuno-oncology, enzyme replacement therapy and other biologics. We have a proven track record in delivery of high value, high profile biologic projects, from innovators to biosimilars.
Antibodies
Monoclonal
Chimeric
Bispecific
Vaccines
Virus production
mRNA: messenger Ribonucleic Acid
AAV: Adeno-Associated Virus
Recombinant hormones
Robust production
Intact glycosylation
Mass fingerprint
Fusion
proteins
High yield
In-depth analytics
Charge complexity
CASE STUDIES
From research to commercial batches, we pay close attention to detail in every project
AstraZeneca COVID-19 Adenoviral vaccine manufacturing
We were AstraZeneca’s chosen manufacturing partner for COVID-19 vaccine in Latin America and EU. The contract was set up in only 3 months with optimal results, including transfer, certification, expansion and optimization.
- Optimal manufacturing deliveries
- Full validation of all processes and technology in record time
- Expansion of capacity and process improvement
- Continuous quality certifications
- +200.000.000 doses delivered
Bevacizumab manufacturing
We have run uninterrupted manufacturing campaigns since 2019 of our biosimilar bevacizumab.
- Manufacturing in Genhelix site, Spain
- Manufactured over 400kgs of Bevacizumab only in 2022
- Global launch with +900,000 vials supplied WW over a 12-month period
- Product approved by FDA, EMA and PMDA